Commentary: Facing the challenge of gene-environment interaction: The two-by-four table and beyond

被引:156
作者
Botto, LD
Khoury, MJ
机构
[1] CDCP, Natl Birth Defects Ctr & Dev Disabil, Birth Defects & Pediat Genet Branch, Atlanta, GA 30341 USA
[2] CDCP, Natl Ctr Environm Hlth, Off Genet & Dis Prevent, Atlanta, GA 30341 USA
关键词
environment; epidemiologic methods; genes; Human Genome Project;
D O I
10.1093/aje/153.10.1016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
As a result of the Human Genome Project, epidemiologists can study thousands of genes and their interaction with the environment. The challenge is how to best present and analyze such studies of multiple genetic and environmental factors. The authors suggest emphasizing the fundamental core of gene-environment interaction-the separate assessment of the effects of individual and joint risk factors. In the simple analysis of one genotype and an exposure (both dichotomous), such study can be summarized in a two-by-four table. The advantages of such a table for data presentation and analysis are many: The table displays the data efficiently and highlights sample size issues; it allows for evaluation of the independent and joint roles of genotype and exposure on disease risk; and it emphasizes effect estimation over model testing. Researchers can easily estimate relative risks and attributable fractions and test different models of interaction. The two-by-four table is a useful tool for presenting, analyzing, and synthesizing data on gene-environment interaction. To highlight the role of gene-environment interaction in disease causation, the authors propose that the two-by-four table is the fundamental unit of epidemiologic analysis.
引用
收藏
页码:1016 / 1020
页数:5
相关论文
共 23 条
[1]   Effect of metylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients [J].
Akar, N ;
Akar, E ;
Akçay, R ;
Avcu, F ;
Yalcin, A ;
Cin, S .
THROMBOSIS RESEARCH, 2000, 97 (03) :163-167
[2]  
BEGG CB, 1994, CANCER EPIDEM BIOMAR, V3, P173
[3]  
Botto LD, 2000, AM J EPIDEMIOL, V151, P862
[4]   The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels [J].
Cattaneo, M ;
Chantarangkul, V ;
Taioli, E ;
Santos, JH ;
Tagliabue, L .
THROMBOSIS RESEARCH, 1999, 93 (01) :1-8
[5]  
Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.0.CO
[6]  
2-T
[7]   New goals for the US Human Genome Project: 1998-2003 [J].
Collins, FS ;
Patrinos, A ;
Jordan, E ;
Chakravarti, A ;
Gesteland, R ;
Walters, L ;
Fearon, E ;
Hartwelt, L ;
Langley, CH ;
Mathies, RA ;
Olson, M ;
Pawson, AJ ;
Pollard, T ;
Williamson, A ;
Wold, B ;
Buetow, K ;
Branscomb, E ;
Capecchi, M ;
Church, G ;
Garner, H ;
Gibbs, RA ;
Hawkins, T ;
Hodgson, K ;
Knotek, M ;
Meisler, M ;
Rubin, GM ;
Smith, LM ;
Smith, RF ;
Westerfield, M ;
Clayton, EW ;
Fisher, NL ;
Lerman, CE ;
McInerney, JD ;
Nebo, W ;
Press, N ;
Valle, D .
SCIENCE, 1998, 282 (5389) :682-689
[8]  
Duh MS, 1998, AM J EPIDEMIOL, V147, P1112
[9]   Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. [J].
Gerhardt, A ;
Scharf, RE ;
Beckmann, MW ;
Struve, S ;
Bender, HG ;
Pillny, M ;
Sandmann, W ;
Zotz, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :374-380
[10]  
Greeland S., 1998, MODERN EPIDEMIOLOGY, P329